384:HKEXChina Gas Holdings Limited Analysis
Data as of 2026-05-22 - not real-time
₩3,565.00
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Coreline Soft is trading at 3,565 KRW, which sits below its 20‑day SMA (3,635) and well under the 200‑day SMA (4,048), indicating a lack of upward momentum. The RSI is near the midpoint at 50.5 and the MACD histogram is sharply negative, flagging bearish technical pressure despite a recent rise in trading volume.
On the fundamentals side, the company posted a robust 48.7% revenue surge, yet operating and profit margins remain in the negative -2.4% and -2.9% respectively, and cash flow is deeply negative. A sizable cash pile (≈35.9 bn KRW) offsets a high debt load (≈21.8 bn KRW, D/E 131%), leaving the balance sheet strained. Valuation metrics such as a price‑to‑sales of 13.6× appear stretched, especially given zero earnings, while the market sentiment is in an "Extreme Greed" phase (Fear‑Greed Index 91).
On the fundamentals side, the company posted a robust 48.7% revenue surge, yet operating and profit margins remain in the negative -2.4% and -2.9% respectively, and cash flow is deeply negative. A sizable cash pile (≈35.9 bn KRW) offsets a high debt load (≈21.8 bn KRW, D/E 131%), leaving the balance sheet strained. Valuation metrics such as a price‑to‑sales of 13.6× appear stretched, especially given zero earnings, while the market sentiment is in an "Extreme Greed" phase (Fear‑Greed Index 91).
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below key moving averages
- Bearish MACD and neutral RSI
- High 30‑day volatility (66%)
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth but persistent negative earnings
- Large cash buffer offsetting high debt
- Continued regulatory and market sentiment uncertainty
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Potential upside from medical‑software adoption
- Need for sustainable profitability and cash‑flow conversion
- Elevated debt level and sector regulatory risk
Key Metrics & Analysis
Financial Health
Revenue Growth48.70%
Profit Margin-292.34%
ROE-137.21%
ROA-21.10%
Debt/Equity131.25
Op. Cash Flow₩-10428107776
Free Cash Flow₩-2863743488
Industry P/E27.3
Technical Analysis
TrendNeutral
RSI50.5
Support₩3,215.00
Resistance₩4,050.00
MA 20₩3,635.25
MA 50₩3,448.70
MA 200₩4,048.35
MACDBearish
VolumeIncreasing
Fear & Greed Index91.02
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.21
Volatility66.66%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.